Making good strides
01/10/24 -"Considering the robust performance this year from both the Companion Animal and Farm Animal segments, and a strong showing from H1 24 in profitability, we have revised upwards our 2024 earnings ..."
Pages
53
Language
English
Published on
01/10/24
You may also be interested by these reports :
10/10/24
GSK agreeing to settle c.93% of Zantac cases for $2.3bn has been well-received by investors, as the figure was lower than the market’s estimate, ...
09/10/24
As a consequence of the upward revision in our earnings estimates, the DCF and the NAV, the overall target price resets some c.13% higher. While we ...
08/10/24
Lundbeck has been surpassing expectations this year, backed by the healthy performances of its four key brands; this has prompted us to revise our ...
01/10/24
Considering the robust performance this year from both the Companion Animal and Farm Animal segments, and a strong showing from H1 24 in ...